Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04089501 · ClinicalTrials.gov registry record
The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 43
- Enrollment target
NCT04089501 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 43 participants.
The verdict
NCT04089501 has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The goal of this study is to better understand the mechanisms responsible for the development of and the severity of Inflammatory Bowel Disease (IBD), such as Crohn's Disease and Ulcerative Colitis, which cause inflammation of the gut as well as potentially affecting other areas of the body
Interventions
- DIAGNOSTIC_TEST Stool collection
- DIAGNOSTIC_TEST Biopsy collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2015-02-25 |
| Est. Completion | 2019-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04089501
The ClinicalTrials.gov registry entry for NCT04089501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stool collection is the first listed.
NCT04089501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04089501 about?
NCT04089501 is a clinical study titled "The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease". The goal of this study is to better understand the mechanisms responsible for the development of and the severity of Inflammatory Bowel Disease (IBD), such as Crohn's Disease and Ulcerative Colitis, which cause inflammation of the gut as well as potentially affecting other areas of the body
What is the current status of trial NCT04089501?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2015-02-25. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT04089501?
The interventions under investigation include: Stool collection (DIAGNOSTIC_TEST), Biopsy collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04089501?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.